Last edition
News about
Bharat Biotech Partners with Bilthoven Biologicals for Oral Polio Vaccines
Bharat Biotech has teamed up with Bilthoven Biologicals, a subsidiary of Serum Institute of India to produce and supply oral polio vaccines (OPVs) worldwide.
Stevanato Group Appoints Ugo Gay as Chief Operations Officer
Stevanato Group S.p.A. announced the appointment of Ugo Gay as its new Chief Operations Officer (COO).
Cadenza Bio Welcomes Michael A. Panzara to its Board of Directors
Cadenza Bio, Inc. has appointed Michael A. Panzara, MD, MPH, to its esteemed board of directors.
TC BioPharm to Boost Treatment Capacity and Slash Costs with Advanced Manufacturing Process
The company's initiative aims to leverage its existing infrastructure to scale up production dramatically, projecting a surge from 52 patient treatments annually to over 1,000.
The acquisition is expected to accelerate Apotex's growth within the specialty branded pharmaceutical market, adding a diverse portfolio of over 60 products and a full-service branded pharmaceutical platform.
Logistics4Pharma Unveils Ultra-Low Temperature Dry Shipper Services
Logistics4Pharma has decided to expand its portfolio of services at its facility in Kelsterbach to include dry shippers.
Affinity Biosensors Gets FDA Clearance for LifeScale AST System
Affinity Biosensors, an innovator in the field of healthcare diagnostics, has declared that its groundbreaking LifeScale AST system has received FDA clearance.
PTx Leukine Gets Approval From Japan PMDA to Treat aPAP
Partner Therapeutics, Inc. has announced that its partner, Nobelpharma received approval from the Japanese Pharmaceuticals and Medical Device Agency (PMDA) for the inhaled use of Leukine.
Olympus Announces FDA Clearance of RenaFlex, its First Single-use Flexible Ureteroscope
The RenaFlex single-use flexible ureteroscope system is used to access and visualize the urinary tract to diagnose and treat urinary diseases and disorders, such as kidney stones.
Asahi Kasei Medical and AW Technologies Sign Agreement for TrachFlush in Japan
AW Technologies is currently in the process of medical device registration of the TrachFlush in Japan, with market launch targeted in fiscal 2024.
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy